We have observed
5 EP applications
Catherine Ann Coombes
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after September 09, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
IMPROVED METHODS FOR DETERMINING CELL VIABILITY USING MOLECULAR NUCLEIC ACID-BASED TECHNIQUES
A GLP-1 ANALOGUE, ITS PREPARATION METHODS AND USE THEREOF
GLUCAGON-LIKE PEPTIDE-1 ANALOGUE MONOMER AND DIMER, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
MARKERS OF ENDOTHELIAL PROGENITOR CELLS AND USES THEREOF